Trevi Therapeutics TRVI 深 沪
等待开盘 10-10 09:30:00 美东时间
9.92
+0.100
+1.02%
华盛通- 最 高10.04
- 今 开9.83
- 成交量 225.40万股
- 最 低 9.59
- 昨 收 9.82
- 总市值 12.10亿
- 52周最高 10.16
- 市盈率 静 --
- 换手率 1.85%
- 52周最低 2.36
- 委 比 -42.82%
- 总股本 1.22亿
- 历史最高 10.62
- 量 比 1.56
- 振 幅 4.58%
- 历史最低 0.46
- 每 手 1
- 风险率 0.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
Professor Philip Molyneaux will give an oral presentation on the key efficacy and safety results from the Phase 2b CORAL trial of nalbuphine ER for the treatment of chronic cough in patients...
10-08 19:30
Trevi Therapeutics to Participate in Upcoming September Conferences
NEW HAVEN, Conn., Aug. 28, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalb...
08-28 19:30
Trevi spikes as B. Riley reportedly cites deal prospects
Trevi Therapeutics (NASDAQ:TRVI), a clinical-stage biopharma focused on treatments for cough conditions, traded higher on Wednesday after B. Riley, with a Buy rating, reportedly highlighted the compan...
08-28 02:48
Trevi Therapeutics CFO Resignation Announced
Trevi Therapeutics ( ($TRVI) ) has issued an announcement. On August 14, 2025, ...
08-21 05:00
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Needham Maintains Buy on Trevi Therapeutics, Lowers Price Target to $22
Needham analyst Serge Belanger maintains Trevi Therapeutics (NASDAQ:TRVI) with a Buy and lowers the price target from $24 to $22.
08-08 19:32
快讯 | Trevi Therapeutics Inc - 宣布Coral 2B期临床试验结果积极
Trevi Therapeutics Inc - Announces Positive Results From Phase 2B Coral Trial
08-08 04:31
快讯 | Trevi Therapeutics Inc - 请求与FDA进行二期结束会议
Trevi Therapeutics Inc - to Request End-of-Phase 2 Meeting With FDA
08-08 04:31
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
